What is the appropriate diagnostic approach for thalassemia?

Diagnostic Approach for Thalassemia

Diagnose thalassemia using a stepwise approach: start with complete blood count (CBC) showing microcytic anemia with elevated RBC count, confirm with hemoglobin analysis (HPLC or capillary electrophoresis), and definitively establish diagnosis with molecular genetic testing.

Initial Screening Tests

Begin with CBC and red cell indices as your first-line screening tool 1, 2:

• α-thalassemia pattern: Elevated RBC count with significantly reduced MCV, MCH, and MCHC
• β-thalassemia pattern: Elevated RDW (red cell distribution width) is the distinguishing feature 1
• Look for microcytic hypochromic anemia disproportionate to the degree of anemia (RBC count often elevated despite low hemoglobin)

Add reticulocyte analysis to enhance diagnostic accuracy 1:

• α-thalassemia: Lower reticulocyte counts (RET#)
• β-thalassemia: Higher immature reticulocyte fraction (IRF)
• A combined model using RBC, MCHC, RET#, and IRF achieves 89.2% specificity for differentiating α- from β-thalassemia 1

Confirmatory Testing

Hemoglobin analysis is essential 2:

• Use high-performance liquid chromatography (HPLC) or hemoglobin capillary-zone electrophoresis
• Identifies abnormal hemoglobin patterns (HbA2, HbF levels)
• Critical caveat: Some rare variants show normal blood indices but abnormal hemoglobin composition, so perform both CBC and hemoglobin electrophoresis together 3

Definitive Molecular Diagnosis

Genetic testing confirms the diagnosis and identifies specific mutations 3, 4:

• Traditional PCR-based methods detect 95-98% of thalassemia carriers but miss rare genotypes 4
• Third-generation sequencing (TGS) is superior for comprehensive diagnosis 3:
  • Detects rare mutations missed by conventional methods (5% higher detection rate)
  • Identifies rare HBA1/2 and HBB mutations in a single test
  • Determines cis/trans configuration of allelic mutations
  • Particularly valuable when phenotype doesn't match expected genotype

Age-Specific Considerations

For neonates, apply age-stratified interpretation 1:

• Hematological parameters differ significantly between ≤28 days and >28 days of age
• Use age-appropriate reference ranges to avoid misdiagnosis

Clinical Pitfalls to Avoid

• Don't rely on blood indices alone: Rare variants may have normal CBC but abnormal hemoglobin composition 3
• Don't skip hemoglobin electrophoresis: Blood routine and hemoglobin analysis must be performed together 3
• Consider iron status: Check ferritin and transferrin saturation, as iron loading can complicate the picture 5
• Beware of misdiagnosis as MDS: Elderly patients with microcytic anemia and ring sideroblasts may have thalassemia, not myelodysplastic syndrome 5

Recommended Diagnostic Algorithm

1. Screen with CBC showing microcytic anemia + elevated RBC count
2. Add reticulocyte parameters (RET#, IRF) for α vs β differentiation
3. Confirm with hemoglobin electrophoresis or HPLC
4. Definitively diagnose with molecular testing (TGS preferred for comprehensive detection)
5. Screen family members once diagnosis confirmed, following X-linked or autosomal recessive inheritance patterns 5